Smith Group Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,930
| Closed | -$319K | – | 171 |
|
|
2026
Q1 | $319K | Sell |
4,930
-3,182
| -39% | -$224K | 0.02% | 155 |
|
|
2025
Q4 | $546K | Buy |
8,112
+722
| +10% | +$48.6K | 0.03% | 130 |
|
|
2025
Q3 | $542K | Buy |
+7,390
| New | +$491K | 0.03% | 125 |
|
|
2022
Q1 | – | Sell |
-150
| Closed | -$6K | – | 318 |
|
|
2021
Q4 | $6K | Hold |
150
| – | – | ﹤0.01% | 339 |
|
|
2021
Q3 | $6K | Hold |
150
| – | – | ﹤0.01% | 342 |
|
|
2021
Q2 | $7K | Hold |
150
| – | – | ﹤0.01% | 328 |
|
|
2021
Q1 | $6K | Sell |
150
-4,290
| -97% | -$196K | ﹤0.01% | 299 |
|
|
2020
Q4 | $190K | Hold |
4,440
| – | – | 0.01% | 183 |
|
|
2020
Q3 | $117K | Sell |
4,440
-850
| -16% | -$23.7K | 0.01% | 191 |
|
|
2020
Q2 | $142K | Sell |
5,290
-60
| -1% | -$1.35K | 0.01% | 181 |
|
|
2020
Q1 | $96K | Hold |
5,350
| – | – | 0.01% | 218 |
|
|
2019
Q4 | $95K | Hold |
5,350
| – | – | ﹤0.01% | 241 |
|
|
2019
Q3 | $83K | Buy |
5,350
+1,370
| +34% | +$22.6K | ﹤0.01% | 247 |
|
|
2019
Q2 | $68K | Hold |
3,980
| – | – | ﹤0.01% | 259 |
|
|
2019
Q1 | $64K | Sell |
3,980
-12,400
| -76% | -$201K | ﹤0.01% | 288 |
|
|
2018
Q4 | $240K | Sell |
16,380
-400
| -2% | -$6.38K | 0.01% | 227 |
|
|
2018
Q3 | $305K | Buy |
16,780
+1,200
| +8% | +$21K | 0.01% | 223 |
|
|
2018
Q2 | $263K | Hold |
15,580
| – | – | 0.01% | 229 |
|
|
2018
Q1 | $305K | Sell |
15,580
-11,400
| -42% | -$221K | 0.01% | 221 |
|
|
2017
Q4 | $547K | Hold |
26,980
| – | – | 0.02% | 201 |
|
|
2017
Q3 | $469K | Hold |
26,980
| – | – | 0.02% | 220 |
|
|
2017
Q2 | $346K | Sell |
26,980
-1,200
| -4% | -$16K | 0.01% | 234 |
|
|
2017
Q1 | $365K | Sell |
28,180
-20
| -0.1% | -$253 | 0.01% | 210 |
|
|
2016
Q4 | $279K | Hold |
28,200
| – | – | 0.01% | 229 |
|
|
2016
Q3 | $341K | Hold |
28,200
| – | – | 0.01% | 211 |
|
|
2016
Q2 | $243K | Sell |
28,200
-300
| -1% | -$2.96K | 0.01% | 232 |
|
|
2016
Q1 | $270K | Sell |
28,500
-14,880
| -34% | -$140K | 0.01% | 184 |
|
|
2015
Q4 | $752K | Sell |
43,380
-6,700
| -13% | -$107K | 0.02% | 186 |
|
|
2015
Q3 | $673K | Buy |
+50,080
| New | +$1.01M | 0.03% | 185 |
|
Other funds holding HALO
Smith Group Asset Management's HALO Position: Q2 2026 in Review
Smith Group Asset Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 4,930 shares — an estimated $319K sold.
Smith Group Asset Management first reported a position in HALO in Q3 2015 and held it in 29 quarters. The position peaked at $752K in Q4 2015. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Smith Group Asset Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
- Smith Group Asset Management sold 4,930 Halozyme shares in Q2 2026, an estimated $319K.
- Smith Group Asset Management first reported a position in Halozyme in Q3 2015 and held it in 29 quarters.
- Smith Group Asset Management's Halozyme position peaked at $752K in Q4 2015.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.